LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 340, Issue 1, 1989, Pages 119-125

  Mulsch A ^a   Luckhoff A ^a   Pohl, U ^a   Busse, R ^a   Bassenge, E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

LY 83583 (6 anilino 5,8 quinolinedione); Platelet activation; Soluble guanylate cyclase; Superoxide anion

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; 8 BROMO CYCLIC GMP; ADENOSINE TRIPHOSPHATE; CALCIUM; CYCLIC GMP; ENDOTHELIUM DERIVED RELAXING FACTOR; GUANYLATE CYCLASE; NITROPRUSSIDE SODIUM; PROSTACYCLIN; SUPEROXIDE DISMUTASE; THROMBIN;

ANIMAL CELL; AORTA; CELL ADHESION; DRUG CONCENTRATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADENOSINE TRIPHOSPHATE; AMINOQUINOLINES; ANIMAL; AORTA, THORACIC; BUFFERS; CALCIUM; CYCLIC GMP; HUMAN; IN VITRO; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITROPRUSSIDE; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; SRS-A; SUPPORT, NON-U.S. GOV'T; SWINE; VASODILATOR AGENTS;

EID: 0024363367     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/BF00169217     Document Type: Article

References (28)

1. Reaction of superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution
2. Endothelium-derived relaxant factor inhibits platelet activation
3. A novel cyclic GMP-lowering agent, LY 83583, blocks carbachol-induced cyclic GMP elevation in rabbit atrial strips without blocking the negative inotropic effect of carbachol
4. Effects of LY 83583, nordihydroguaiaretic acid, and quinacrine on cyclic GMP elevation and inhibition of tension by muscarinic agonists in rabbit aorta and left atrium
5. The role of endothelium in the responses of vascular smooth muscle to drugs
6. Intracellular production of superoxide radical and of hydrogen peroxide by redox active compounds
7. The pharmacological and the physiological role of cyclic GMP in vascular smooth muscle relaxation
8. Potentiation of platelet aggregation by atrial natriuretic peptide
9. Protein measurement with phenol reagent
10. Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to α-adrenoceptor stimulation
11. Effect of LY 83583 on relaxant responses and levels of cyclic GMP in rat aorta
12. LY 83583 interferes with the release of endothelium-derived relaxant factor and inhibits soluble guanylate cyclase
13. LY 83583 interferes with the production of endothelium-derived relaxing factor (EDRF) and inhibits soluble guanylate cyclase
14. Regulation of cyclic GMP synthesis and the interactions with calcium
15. Inhibitory role of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human platelets
16. The role of protein kinase C in cell surface signal transduction and tumor promotion
17. − cotransport in vascular smooth muscle cells
18. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
19. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium
20. Reduction-potential of glutathione
21. LY 83583: an agent that lowers intracellular levels of cyclic guanosine 3′,5′-monophosphate
22. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells
23. Radioimmunoassay for cyclic nucleotides
24. Inhibitory action of guanosine 3′,5′-monophosphate on thrombin-induced phosphatidylinositol turnover and protein phosphorylation in human platelets
25. Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP-and cGMP-dependent protein kinases
26. Some statistical methods useful in circulation research
27. Synergistic functions of phorbol ester and calcium in serotonin release from human platelets